Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.17583704 |
2 | drug transmembrane transport (GO:0006855) | 9.16671863 |
3 | urate metabolic process (GO:0046415) | 9.03616494 |
4 | actin filament depolymerization (GO:0030042) | 8.27735841 |
5 | lysine catabolic process (GO:0006554) | 8.16755326 |
6 | lysine metabolic process (GO:0006553) | 8.16755326 |
7 | drug transport (GO:0015893) | 7.73868534 |
8 | organic cation transport (GO:0015695) | 7.56986284 |
9 | phosphate ion transport (GO:0006817) | 7.14679327 |
10 | collecting duct development (GO:0072044) | 7.04586877 |
11 | excretion (GO:0007588) | 6.74252373 |
12 | cardiovascular system development (GO:0072358) | 6.74023021 |
13 | valine metabolic process (GO:0006573) | 6.58436777 |
14 | response to mercury ion (GO:0046689) | 6.31952771 |
15 | quaternary ammonium group transport (GO:0015697) | 6.28007060 |
16 | renal absorption (GO:0070293) | 6.26609685 |
17 | phosphate ion transmembrane transport (GO:0035435) | 5.93705403 |
18 | branched-chain amino acid metabolic process (GO:0009081) | 5.82722539 |
19 | metanephric nephron tubule development (GO:0072234) | 5.74209424 |
20 | metanephric tubule development (GO:0072170) | 5.74209424 |
21 | response to water (GO:0009415) | 5.70196443 |
22 | tricarboxylic acid metabolic process (GO:0072350) | 5.65198675 |
23 | cysteine metabolic process (GO:0006534) | 5.64430914 |
24 | short-chain fatty acid metabolic process (GO:0046459) | 5.53147895 |
25 | 2-oxoglutarate metabolic process (GO:0006103) | 5.41270398 |
26 | aspartate family amino acid catabolic process (GO:0009068) | 5.39469293 |
27 | metanephric nephron epithelium development (GO:0072243) | 5.26782235 |
28 | toxin transport (GO:1901998) | 5.20230285 |
29 | glyoxylate metabolic process (GO:0046487) | 5.15721121 |
30 | cell volume homeostasis (GO:0006884) | 5.08076749 |
31 | response to lead ion (GO:0010288) | 5.06830837 |
32 | homocysteine metabolic process (GO:0050667) | 5.04705250 |
33 | response to thyroid hormone (GO:0097066) | 5.00651461 |
34 | muscle filament sliding (GO:0030049) | 4.98389852 |
35 | actin-myosin filament sliding (GO:0033275) | 4.98389852 |
36 | metanephric epithelium development (GO:0072207) | 4.97410545 |
37 | branched-chain amino acid catabolic process (GO:0009083) | 4.96486909 |
38 | response to magnesium ion (GO:0032026) | 4.95503449 |
39 | drug catabolic process (GO:0042737) | 4.85665322 |
40 | cellular modified amino acid catabolic process (GO:0042219) | 4.84471136 |
41 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.72464682 |
42 | polyol transport (GO:0015791) | 4.71452854 |
43 | vitamin D metabolic process (GO:0042359) | 4.70364437 |
44 | glycoside metabolic process (GO:0016137) | 4.67425680 |
45 | carnitine transport (GO:0015879) | 4.64709472 |
46 | amino-acid betaine transport (GO:0015838) | 4.64709472 |
47 | proline metabolic process (GO:0006560) | 4.62772686 |
48 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.55380046 |
49 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.47747990 |
50 | inositol metabolic process (GO:0006020) | 4.46682280 |
51 | exogenous drug catabolic process (GO:0042738) | 4.45282986 |
52 | modified amino acid transport (GO:0072337) | 4.38089978 |
53 | phosphate ion homeostasis (GO:0055062) | 4.28336523 |
54 | trivalent inorganic anion homeostasis (GO:0072506) | 4.28336523 |
55 | actin-mediated cell contraction (GO:0070252) | 4.26950822 |
56 | peptide catabolic process (GO:0043171) | 4.26390838 |
57 | regulation of skeletal muscle contraction (GO:0014819) | 4.24369978 |
58 | indolalkylamine catabolic process (GO:0046218) | 4.24187776 |
59 | tryptophan catabolic process (GO:0006569) | 4.24187776 |
60 | indole-containing compound catabolic process (GO:0042436) | 4.24187776 |
61 | nephron tubule development (GO:0072080) | 4.22736014 |
62 | aromatic amino acid family catabolic process (GO:0009074) | 4.10854612 |
63 | tryptophan metabolic process (GO:0006568) | 4.10324885 |
64 | fatty acid beta-oxidation (GO:0006635) | 4.07199464 |
65 | glutathione biosynthetic process (GO:0006750) | 4.05385254 |
66 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 4.04564885 |
67 | fructose metabolic process (GO:0006000) | 3.99247341 |
68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97958886 |
69 | L-phenylalanine metabolic process (GO:0006558) | 3.96388061 |
70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.96388061 |
71 | L-phenylalanine catabolic process (GO:0006559) | 3.91654191 |
72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.91654191 |
73 | nephron tubule formation (GO:0072079) | 3.91371315 |
74 | biotin metabolic process (GO:0006768) | 3.90996632 |
75 | acetyl-CoA metabolic process (GO:0006084) | 3.90106303 |
76 | negative regulation of protein localization to cell surface (GO:2000009) | 3.89831161 |
77 | serine family amino acid catabolic process (GO:0009071) | 3.86656784 |
78 | fatty acid oxidation (GO:0019395) | 3.86140013 |
79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.84224879 |
80 | creatine metabolic process (GO:0006600) | 3.84139316 |
81 | amino-acid betaine metabolic process (GO:0006577) | 3.81241607 |
82 | lipid oxidation (GO:0034440) | 3.78657706 |
83 | hyperosmotic response (GO:0006972) | 3.75961444 |
84 | renal tubule development (GO:0061326) | 3.74467620 |
85 | response to phenylpropanoid (GO:0080184) | 3.72068151 |
86 | oxaloacetate metabolic process (GO:0006107) | 3.69559242 |
87 | response to copper ion (GO:0046688) | 3.67529713 |
88 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.67201300 |
89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65797320 |
90 | serine family amino acid metabolic process (GO:0009069) | 3.65654235 |
91 | NADH metabolic process (GO:0006734) | 3.59958151 |
92 | sulfur compound transport (GO:0072348) | 3.55938850 |
93 | glutamate metabolic process (GO:0006536) | 3.54646099 |
94 | cellular amino acid catabolic process (GO:0009063) | 3.53607599 |
95 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.53604371 |
96 | sulfur amino acid catabolic process (GO:0000098) | 3.50423031 |
97 | vitamin transport (GO:0051180) | 3.49997989 |
98 | cellular ketone body metabolic process (GO:0046950) | 3.49803085 |
99 | kynurenine metabolic process (GO:0070189) | 3.49601078 |
100 | carnitine metabolic process (GO:0009437) | 3.49590377 |
101 | negative regulation of metanephros development (GO:0072217) | 3.48671652 |
102 | nephron epithelium development (GO:0072009) | 3.47786969 |
103 | bone remodeling (GO:0046849) | 3.45171730 |
104 | succinate metabolic process (GO:0006105) | 3.43886049 |
105 | beta-amyloid metabolic process (GO:0050435) | 3.43645616 |
106 | oligosaccharide catabolic process (GO:0009313) | 3.40354634 |
107 | regulation of relaxation of muscle (GO:1901077) | 3.40161183 |
108 | vitamin transmembrane transport (GO:0035461) | 3.35226580 |
109 | fatty acid catabolic process (GO:0009062) | 3.33807729 |
110 | thrombin receptor signaling pathway (GO:0070493) | 3.31579741 |
111 | peptide biosynthetic process (GO:0043043) | 3.30660788 |
112 | skeletal muscle contraction (GO:0003009) | 3.29897918 |
113 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.29543540 |
114 | alpha-amino acid catabolic process (GO:1901606) | 3.28577467 |
115 | sodium-independent organic anion transport (GO:0043252) | 3.27641671 |
116 | sodium ion transport (GO:0006814) | 3.27371851 |
117 | transepithelial transport (GO:0070633) | 3.26158232 |
118 | water transport (GO:0006833) | 3.24685577 |
119 | nephron tubule morphogenesis (GO:0072078) | 3.23105392 |
120 | nephron epithelium morphogenesis (GO:0072088) | 3.23105392 |
121 | actin filament-based movement (GO:0030048) | 3.21833630 |
122 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.21438126 |
123 | myofibril assembly (GO:0030239) | 3.21341803 |
124 | response to growth hormone (GO:0060416) | 3.21310055 |
125 | response to parathyroid hormone (GO:0071107) | 3.18976073 |
126 | sarcomere organization (GO:0045214) | 3.18883753 |
127 | cobalamin metabolic process (GO:0009235) | 3.18745791 |
128 | surfactant homeostasis (GO:0043129) | 3.17118120 |
129 | indole-containing compound metabolic process (GO:0042430) | 3.16340370 |
130 | organic acid catabolic process (GO:0016054) | 3.16156670 |
131 | carboxylic acid catabolic process (GO:0046395) | 3.16156670 |
132 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.15860465 |
133 | cellular response to ammonium ion (GO:0071242) | 3.14849941 |
134 | response to vitamin A (GO:0033189) | 3.14618046 |
135 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.12295642 |
136 | fucose metabolic process (GO:0006004) | 3.09932682 |
137 | monocarboxylic acid catabolic process (GO:0072329) | 3.08582016 |
138 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.07994027 |
139 | L-methionine salvage (GO:0071267) | 3.07925856 |
140 | L-methionine biosynthetic process (GO:0071265) | 3.07925856 |
141 | amino acid salvage (GO:0043102) | 3.07925856 |
142 | dicarboxylic acid metabolic process (GO:0043648) | 3.06825740 |
143 | protein depolymerization (GO:0051261) | 3.06820862 |
144 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.00906622 |
145 | renal system process (GO:0003014) | 2.98662213 |
146 | relaxation of muscle (GO:0090075) | 2.98234771 |
147 | protein neddylation (GO:0045116) | 2.95502432 |
148 | skeletal muscle tissue regeneration (GO:0043403) | 2.92039288 |
149 | pattern specification involved in kidney development (GO:0061004) | 2.88932136 |
150 | regulation of anion transport (GO:0044070) | 2.86031950 |
151 | striated muscle contraction (GO:0006941) | 2.86007799 |
152 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.84756975 |
153 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84274675 |
154 | fluid transport (GO:0042044) | 2.83856240 |
155 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.79533638 |
156 | regulation of lipoprotein metabolic process (GO:0050746) | 2.77714100 |
157 | regulation of fever generation (GO:0031620) | 2.75580401 |
158 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.74437185 |
159 | cellular carbohydrate catabolic process (GO:0044275) | 2.73736997 |
160 | response to salt stress (GO:0009651) | 2.72982189 |
161 | regulation of stem cell maintenance (GO:2000036) | 2.72284307 |
162 | relaxation of cardiac muscle (GO:0055119) | 2.72131519 |
163 | response to muscle activity (GO:0014850) | 2.71806682 |
164 | regulation of sulfur metabolic process (GO:0042762) | 2.69057786 |
165 | carnitine shuttle (GO:0006853) | 2.67711051 |
166 | urogenital system development (GO:0001655) | 2.65373419 |
167 | chloride transmembrane transport (GO:1902476) | 2.62006216 |
168 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.61064166 |
169 | glycogen catabolic process (GO:0005980) | 2.58725670 |
170 | regulation of platelet aggregation (GO:0090330) | 2.55319237 |
171 | S-adenosylmethionine metabolic process (GO:0046500) | 2.54772334 |
172 | glomerular visceral epithelial cell development (GO:0072015) | 2.54204111 |
173 | positive regulation of heat generation (GO:0031652) | 2.51362612 |
174 | neuronal action potential propagation (GO:0019227) | 2.50003852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.06997842 |
2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.92711827 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89872085 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.39363016 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.21159645 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18339158 |
7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.80713672 |
8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.78787023 |
9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.55515407 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.52314192 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.51175289 |
12 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.50466556 |
13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.34844871 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.31194809 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.26488974 |
16 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.26208659 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18449991 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.17523706 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08340288 |
20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.04925999 |
21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.04694283 |
22 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02086630 |
23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01251977 |
24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99982528 |
25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.94536619 |
26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92805958 |
27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91310627 |
28 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.89078920 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80266787 |
30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.77800184 |
31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.76726943 |
32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.74965727 |
33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73920369 |
34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73073353 |
35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72562383 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70923146 |
37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67948181 |
38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.67879259 |
39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64602534 |
40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.64585225 |
41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.60571790 |
42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.60256026 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57729965 |
44 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.57144563 |
45 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.55486614 |
46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55404095 |
47 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.54228909 |
48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51810625 |
49 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51782792 |
50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49019670 |
51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48583498 |
52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48126088 |
53 | RXR_22108803_ChIP-Seq_LS180_Human | 1.46316859 |
54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45322360 |
55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43313262 |
56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42284754 |
57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38348019 |
58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37905719 |
59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37590467 |
60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36893998 |
61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.34990971 |
62 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34153937 |
63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33703206 |
64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32754289 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32339119 |
66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32008407 |
67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31337145 |
68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31019892 |
69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.30961580 |
70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.30961580 |
71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.30718775 |
72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30242705 |
73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.29804283 |
74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29591816 |
75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28827453 |
76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26386539 |
77 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25768867 |
78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24901664 |
79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23329888 |
80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22932872 |
81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22653516 |
82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22619235 |
83 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.21748051 |
84 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19721322 |
85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16290650 |
86 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15986944 |
87 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15017186 |
88 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14916283 |
89 | TBL1_22424771_ChIP-Seq_293T_Human | 1.14873874 |
90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.13512330 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12275812 |
92 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.12178524 |
93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.12174280 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11791383 |
95 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09591425 |
96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08639085 |
97 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.08612079 |
98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08609866 |
99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08430015 |
100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08269663 |
101 | CBP_21632823_ChIP-Seq_H3396_Human | 1.07400831 |
102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07278185 |
103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06129999 |
104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06113425 |
105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05770211 |
106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05477320 |
107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05347165 |
108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04908699 |
109 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.03653428 |
110 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03394702 |
111 | NFYA_21822215_ChIP-Seq_K562_Human | 1.03119918 |
112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02833113 |
113 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 1.02373219 |
114 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.02366603 |
115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02365393 |
116 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01869974 |
117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01734314 |
118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01734314 |
119 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01625839 |
120 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00535663 |
121 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.99943394 |
122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99741041 |
123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99406073 |
124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98587920 |
125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98535409 |
126 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97985915 |
127 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97845033 |
128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97542223 |
129 | NFYB_21822215_ChIP-Seq_K562_Human | 0.97339336 |
130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96475170 |
131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95806464 |
132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93777397 |
133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93544872 |
134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93080984 |
135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93024530 |
136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92585257 |
137 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92146067 |
138 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90090299 |
139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89536693 |
140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89012339 |
141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88974311 |
142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87967863 |
143 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86882164 |
144 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86717563 |
145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86703433 |
146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.85384895 |
147 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83887183 |
148 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83160809 |
149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82619450 |
150 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81579125 |
151 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81450255 |
152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80908566 |
153 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80738750 |
154 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80075525 |
155 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78896253 |
156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.77406000 |
157 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74342805 |
158 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72632515 |
159 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72024838 |
160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71145412 |
161 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71145412 |
162 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71072100 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 8.01108004 |
2 | MP0005360_urolithiasis | 6.00706499 |
3 | MP0005332_abnormal_amino_acid | 4.70102141 |
4 | MP0001765_abnormal_ion_homeostasis | 4.38108585 |
5 | MP0003195_calcinosis | 4.37960268 |
6 | MP0009643_abnormal_urine_homeostasis | 4.09893848 |
7 | MP0004019_abnormal_vitamin_homeostasis | 4.02624753 |
8 | MP0001756_abnormal_urination | 3.99146383 |
9 | MP0002139_abnormal_hepatobiliary_system | 3.54630529 |
10 | MP0005636_abnormal_mineral_homeostasis | 3.36177508 |
11 | MP0002136_abnormal_kidney_physiology | 3.18369596 |
12 | MP0002138_abnormal_hepatobiliary_system | 3.17034376 |
13 | MP0005464_abnormal_platelet_physiology | 2.37249850 |
14 | MP0003300_gastrointestinal_ulcer | 2.35161208 |
15 | MP0004036_abnormal_muscle_relaxation | 2.33929079 |
16 | MP0008004_abnormal_stomach_pH | 2.29764078 |
17 | MP0004084_abnormal_cardiac_muscle | 2.27350890 |
18 | MP0003878_abnormal_ear_physiology | 2.27344472 |
19 | MP0005377_hearing/vestibular/ear_phenot | 2.27344472 |
20 | MP0001958_emphysema | 2.22765013 |
21 | MP0003252_abnormal_bile_duct | 2.16719443 |
22 | MP0005365_abnormal_bile_salt | 2.11278114 |
23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.09363601 |
24 | MP0004145_abnormal_muscle_electrophysio | 2.05498537 |
25 | MP0000749_muscle_degeneration | 2.01566901 |
26 | MP0008961_abnormal_basal_metabolism | 1.97749318 |
27 | MP0000538_abnormal_urinary_bladder | 1.93294666 |
28 | MP0005058_abnormal_lysosome_morphology | 1.88336411 |
29 | MP0010234_abnormal_vibrissa_follicle | 1.79858976 |
30 | MP0000751_myopathy | 1.79612180 |
31 | MP0000230_abnormal_systemic_arterial | 1.62975281 |
32 | MP0005310_abnormal_salivary_gland | 1.61722479 |
33 | MP0004885_abnormal_endolymph | 1.61450417 |
34 | MP0002876_abnormal_thyroid_physiology | 1.60558491 |
35 | MP0004130_abnormal_muscle_cell | 1.60196636 |
36 | MP0003186_abnormal_redox_activity | 1.57740315 |
37 | MP0004215_abnormal_myocardial_fiber | 1.57643930 |
38 | MP0005451_abnormal_body_composition | 1.53548043 |
39 | MP0010386_abnormal_urinary_bladder | 1.50995537 |
40 | MP0004510_myositis | 1.49041665 |
41 | MP0001666_abnormal_nutrient_absorption | 1.42823826 |
42 | MP0005620_abnormal_muscle_contractility | 1.42440684 |
43 | MP0005085_abnormal_gallbladder_physiolo | 1.40325686 |
44 | MP0002135_abnormal_kidney_morphology | 1.36174229 |
45 | MP0002106_abnormal_muscle_physiology | 1.31778235 |
46 | MP0005220_abnormal_exocrine_pancreas | 1.31548028 |
47 | MP0004264_abnormal_extraembryonic_tissu | 1.31447509 |
48 | MP0005319_abnormal_enzyme/_coenzyme | 1.29494428 |
49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29464684 |
50 | MP0004087_abnormal_muscle_fiber | 1.25346300 |
51 | MP0002972_abnormal_cardiac_muscle | 1.24252827 |
52 | MP0002168_other_aberrant_phenotype | 1.23863495 |
53 | MP0005369_muscle_phenotype | 1.11081286 |
54 | MP0002928_abnormal_bile_duct | 1.10847187 |
55 | MP0005647_abnormal_sex_gland | 1.10699148 |
56 | MP0003879_abnormal_hair_cell | 1.10461492 |
57 | MP0009764_decreased_sensitivity_to | 1.08639771 |
58 | MP0008775_abnormal_heart_ventricle | 1.07034917 |
59 | MP0002896_abnormal_bone_mineralization | 1.05538992 |
60 | MP0005084_abnormal_gallbladder_morpholo | 1.04594393 |
61 | MP0001764_abnormal_homeostasis | 1.01780063 |
62 | MP0004147_increased_porphyrin_level | 1.00172575 |
63 | MP0002166_altered_tumor_susceptibility | 0.99705279 |
64 | MP0003283_abnormal_digestive_organ | 0.99396810 |
65 | MP0006036_abnormal_mitochondrial_physio | 0.97780928 |
66 | MP0005666_abnormal_adipose_tissue | 0.97749882 |
67 | MP0005535_abnormal_body_temperature | 0.97078290 |
68 | MP0008872_abnormal_physiological_respon | 0.96030760 |
69 | MP0002269_muscular_atrophy | 0.92107090 |
70 | MP0003959_abnormal_lean_body | 0.91627882 |
71 | MP0005330_cardiomyopathy | 0.90799565 |
72 | MP0000759_abnormal_skeletal_muscle | 0.90734520 |
73 | MP0003638_abnormal_response/metabolism_ | 0.90694462 |
74 | MP0009672_abnormal_birth_weight | 0.88024141 |
75 | MP0005670_abnormal_white_adipose | 0.87380498 |
76 | MP0002332_abnormal_exercise_endurance | 0.87346651 |
77 | MP0005083_abnormal_biliary_tract | 0.84564606 |
78 | MP0000465_gastrointestinal_hemorrhage | 0.84330172 |
79 | MP0001544_abnormal_cardiovascular_syste | 0.79583168 |
80 | MP0005385_cardiovascular_system_phenoty | 0.79583168 |
81 | MP0006138_congestive_heart_failure | 0.77910779 |
82 | MP0001661_extended_life_span | 0.77425973 |
83 | MP0000534_abnormal_ureter_morphology | 0.76953701 |
84 | MP0002118_abnormal_lipid_homeostasis | 0.74932388 |
85 | MP0009642_abnormal_blood_homeostasis | 0.72444938 |
86 | MP0000747_muscle_weakness | 0.71917857 |
87 | MP0002127_abnormal_cardiovascular_syste | 0.67827917 |
88 | MP0002971_abnormal_brown_adipose | 0.67777878 |
89 | MP0009780_abnormal_chondrocyte_physiolo | 0.66497186 |
90 | MP0003646_muscle_fatigue | 0.66096997 |
91 | MP0010630_abnormal_cardiac_muscle | 0.65913291 |
92 | MP0003566_abnormal_cell_adhesion | 0.65767387 |
93 | MP0003137_abnormal_impulse_conducting | 0.63497922 |
94 | MP0005395_other_phenotype | 0.63395902 |
95 | MP0001879_abnormal_lymphatic_vessel | 0.61335343 |
96 | MP0001664_abnormal_digestion | 0.60631880 |
97 | MP0002089_abnormal_postnatal_growth/wei | 0.59175343 |
98 | MP0002108_abnormal_muscle_morphology | 0.58695526 |
99 | MP0004272_abnormal_basement_membrane | 0.58468456 |
100 | MP0001873_stomach_inflammation | 0.57332230 |
101 | MP0002006_tumorigenesis | 0.56903425 |
102 | MP0005165_increased_susceptibility_to | 0.55754436 |
103 | MP0003828_pulmonary_edema | 0.55646215 |
104 | MP0000750_abnormal_muscle_regeneration | 0.54743609 |
105 | MP0002295_abnormal_pulmonary_circulatio | 0.54563545 |
106 | MP0004085_abnormal_heartbeat | 0.54457408 |
107 | MP0000537_abnormal_urethra_morphology | 0.53718850 |
108 | MP0003136_yellow_coat_color | 0.53612704 |
109 | MP0002078_abnormal_glucose_homeostasis | 0.53048209 |
110 | MP0000371_diluted_coat_color | 0.51793981 |
111 | MP0001944_abnormal_pancreas_morphology | 0.51203583 |
112 | MP0003315_abnormal_perineum_morphology | 0.50838245 |
113 | MP0003795_abnormal_bone_structure | 0.50297668 |
114 | MP0008469_abnormal_protein_level | 0.50288637 |
115 | MP0003191_abnormal_cellular_cholesterol | 0.50211651 |
116 | MP0000609_abnormal_liver_physiology | 0.49740099 |
117 | MP0001270_distended_abdomen | 0.49431604 |
118 | MP0003806_abnormal_nucleotide_metabolis | 0.49423379 |
119 | MP0000013_abnormal_adipose_tissue | 0.48812639 |
120 | MP0002796_impaired_skin_barrier | 0.48452374 |
121 | MP0004233_abnormal_muscle_weight | 0.48048254 |
122 | MP0002098_abnormal_vibrissa_morphology | 0.47989021 |
123 | MP0009765_abnormal_xenobiotic_induced | 0.47632582 |
124 | MP0004484_altered_response_of | 0.47457094 |
125 | MP0010368_abnormal_lymphatic_system | 0.46984910 |
126 | MP0001663_abnormal_digestive_system | 0.46556250 |
127 | MP0003172_abnormal_lysosome_physiology | 0.46423790 |
128 | MP0002069_abnormal_eating/drinking_beha | 0.46372933 |
129 | MP0002115_abnormal_skeleton_extremities | 0.46021899 |
130 | MP0003183_abnormal_peptide_metabolism | 0.45876202 |
131 | MP0001191_abnormal_skin_condition | 0.45664055 |
132 | MP0003953_abnormal_hormone_level | 0.45272391 |
133 | MP0005166_decreased_susceptibility_to | 0.45227001 |
134 | MP0009703_decreased_birth_body | 0.44808149 |
135 | MP0002128_abnormal_blood_circulation | 0.44721267 |
136 | MP0005375_adipose_tissue_phenotype | 0.44217129 |
137 | MP0010329_abnormal_lipoprotein_level | 0.43810869 |
138 | MP0005408_hypopigmentation | 0.43542700 |
139 | MP0003724_increased_susceptibility_to | 0.42055512 |
140 | MP0003011_delayed_dark_adaptation | 0.40374588 |
141 | MP0003045_fibrosis | 0.40114399 |
142 | MP0002998_abnormal_bone_remodeling | 0.39418234 |
143 | MP0000163_abnormal_cartilage_morphology | 0.38513224 |
144 | MP0003656_abnormal_erythrocyte_physiolo | 0.37770122 |
145 | MP0001784_abnormal_fluid_regulation | 0.37438456 |
146 | MP0000598_abnormal_liver_morphology | 0.36598320 |
147 | MP0006054_spinal_hemorrhage | 0.36547725 |
148 | MP0005381_digestive/alimentary_phenotyp | 0.35847153 |
149 | MP0001845_abnormal_inflammatory_respons | 0.35407946 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased circulating renin level (HP:0000848) | 9.11905920 |
2 | Hypokalemic alkalosis (HP:0001949) | 8.48986586 |
3 | Metabolic alkalosis (HP:0200114) | 8.17027387 |
4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.66375751 |
5 | Abnormality of chloride homeostasis (HP:0011422) | 7.22864109 |
6 | Polyuria (HP:0000103) | 7.22162861 |
7 | Abnormal urine output (HP:0012590) | 6.95077185 |
8 | * Hypomagnesemia (HP:0002917) | 6.87061395 |
9 | Abnormality of renal excretion (HP:0011036) | 6.49051955 |
10 | Gout (HP:0001997) | 6.26097491 |
11 | Abnormal drinking behavior (HP:0030082) | 6.09218029 |
12 | Polydipsia (HP:0001959) | 6.09218029 |
13 | Tetany (HP:0001281) | 5.88280457 |
14 | * Abnormality of magnesium homeostasis (HP:0004921) | 5.70981336 |
15 | Abnormality of renin-angiotensin system (HP:0000847) | 5.41251713 |
16 | Renal salt wasting (HP:0000127) | 5.38749044 |
17 | Hyperaldosteronism (HP:0000859) | 5.38619930 |
18 | Alkalosis (HP:0001948) | 5.13867660 |
19 | Proximal tubulopathy (HP:0000114) | 4.75089477 |
20 | Hyperglycinuria (HP:0003108) | 4.70105465 |
21 | Hyperuricemia (HP:0002149) | 4.51094583 |
22 | Increased purine levels (HP:0004368) | 4.51094583 |
23 | Hypokalemia (HP:0002900) | 4.48379529 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09218796 |
25 | Abnormality of purine metabolism (HP:0004352) | 3.89278672 |
26 | Abnormality of glycine metabolism (HP:0010895) | 3.76615012 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76615012 |
28 | Abnormality of potassium homeostasis (HP:0011042) | 3.73588405 |
29 | Hypercalciuria (HP:0002150) | 3.67955516 |
30 | Nemaline bodies (HP:0003798) | 3.60119177 |
31 | Generalized aminoaciduria (HP:0002909) | 3.50833214 |
32 | Muscle fiber inclusion bodies (HP:0100299) | 3.50746118 |
33 | Ketoacidosis (HP:0001993) | 3.49239814 |
34 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.43025374 |
35 | Renal tubular acidosis (HP:0001947) | 3.12369357 |
36 | Hydroxyprolinuria (HP:0003080) | 3.01272775 |
37 | Abnormality of proline metabolism (HP:0010907) | 3.01272775 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.99343861 |
39 | Ketosis (HP:0001946) | 2.93746232 |
40 | Glycosuria (HP:0003076) | 2.89379712 |
41 | Abnormality of urine glucose concentration (HP:0011016) | 2.89379712 |
42 | Abnormality of sodium homeostasis (HP:0010931) | 2.78666912 |
43 | Vacuolated lymphocytes (HP:0001922) | 2.74905414 |
44 | Nephrocalcinosis (HP:0000121) | 2.74904071 |
45 | Facial shape deformation (HP:0011334) | 2.72841252 |
46 | Potter facies (HP:0002009) | 2.72841252 |
47 | Hyponatremia (HP:0002902) | 2.71934910 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.70655719 |
49 | Large eyes (HP:0001090) | 2.66465568 |
50 | Hyperglycinemia (HP:0002154) | 2.59218411 |
51 | Abnormal platelet function (HP:0011869) | 2.58753580 |
52 | Impaired platelet aggregation (HP:0003540) | 2.58753580 |
53 | Dehydration (HP:0001944) | 2.57913082 |
54 | Exercise-induced myalgia (HP:0003738) | 2.55608981 |
55 | Widely patent fontanelles and sutures (HP:0004492) | 2.51810002 |
56 | Adrenal overactivity (HP:0002717) | 2.43506741 |
57 | Vascular calcification (HP:0004934) | 2.39672278 |
58 | Hyperphosphaturia (HP:0003109) | 2.39072437 |
59 | Exercise-induced muscle cramps (HP:0003710) | 2.38016174 |
60 | Abnormal urine phosphate concentration (HP:0012599) | 2.34527823 |
61 | Delayed epiphyseal ossification (HP:0002663) | 2.32500941 |
62 | Type 1 muscle fiber predominance (HP:0003803) | 2.32487893 |
63 | Chondrocalcinosis (HP:0000934) | 2.30550703 |
64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.26011196 |
65 | Hypophosphatemia (HP:0002148) | 2.25967477 |
66 | Nephrolithiasis (HP:0000787) | 2.23002431 |
67 | Tubular atrophy (HP:0000092) | 2.19556622 |
68 | Abnormality of Sharpey fibers (HP:0100685) | 2.18126624 |
69 | Glomerulosclerosis (HP:0000096) | 2.14156297 |
70 | Cardiovascular calcification (HP:0011915) | 2.12196868 |
71 | Abnormality of renal resorption (HP:0011038) | 2.11270795 |
72 | Increased mean platelet volume (HP:0011877) | 2.11242506 |
73 | Tubulointerstitial fibrosis (HP:0005576) | 2.05862622 |
74 | Rickets (HP:0002748) | 2.05588296 |
75 | Generalized muscle weakness (HP:0003324) | 2.04666220 |
76 | Metaphyseal cupping (HP:0003021) | 2.04272945 |
77 | Hypotension (HP:0002615) | 2.02010876 |
78 | Menorrhagia (HP:0000132) | 2.00679129 |
79 | Delayed CNS myelination (HP:0002188) | 2.00062101 |
80 | Prolonged bleeding time (HP:0003010) | 1.98443852 |
81 | Vomiting (HP:0002013) | 1.97895685 |
82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.95856563 |
83 | Metabolic acidosis (HP:0001942) | 1.95302130 |
84 | Hyperammonemia (HP:0001987) | 1.95055919 |
85 | Enlarged kidneys (HP:0000105) | 1.94009487 |
86 | Abnormal tarsal ossification (HP:0008369) | 1.92590197 |
87 | Abnormality of cochlea (HP:0000375) | 1.90722795 |
88 | Abnormal platelet volume (HP:0011876) | 1.90355303 |
89 | Renal tubular dysfunction (HP:0000124) | 1.81417327 |
90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80824454 |
91 | Dicarboxylic aciduria (HP:0003215) | 1.80824454 |
92 | Decreased circulating renin level (HP:0003351) | 1.76539459 |
93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75159389 |
94 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.73907009 |
95 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73003829 |
96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72646346 |
97 | Hyperkalemia (HP:0002153) | 1.72011898 |
98 | Malnutrition (HP:0004395) | 1.70068622 |
99 | Muscle fiber splitting (HP:0003555) | 1.69860634 |
100 | Lymphangioma (HP:0100764) | 1.69650179 |
101 | Petechiae (HP:0000967) | 1.69096744 |
102 | Abnormality of the costochondral junction (HP:0000919) | 1.68527104 |
103 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.66765073 |
104 | Methylmalonic aciduria (HP:0012120) | 1.62127325 |
105 | Thin bony cortex (HP:0002753) | 1.61901663 |
106 | Tachypnea (HP:0002789) | 1.60317936 |
107 | Paralysis (HP:0003470) | 1.59433831 |
108 | Calf muscle hypertrophy (HP:0008981) | 1.58502714 |
109 | Myoglobinuria (HP:0002913) | 1.56915982 |
110 | Dysostosis multiplex (HP:0000943) | 1.56707683 |
111 | Lethargy (HP:0001254) | 1.56475237 |
112 | Confusion (HP:0001289) | 1.55465806 |
113 | Bicornuate uterus (HP:0000813) | 1.53947031 |
114 | Mucopolysacchariduria (HP:0008155) | 1.48473967 |
115 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.48473967 |
116 | Rhabdomyolysis (HP:0003201) | 1.47685294 |
117 | Myopathic facies (HP:0002058) | 1.46415431 |
118 | Abnormality of the renal cortex (HP:0011035) | 1.46303626 |
119 | Distal arthrogryposis (HP:0005684) | 1.45009118 |
120 | Elevated alkaline phosphatase (HP:0003155) | 1.44316007 |
121 | EMG: myopathic abnormalities (HP:0003458) | 1.44124492 |
122 | Wide cranial sutures (HP:0010537) | 1.43764919 |
123 | Hyporeflexia of lower limbs (HP:0002600) | 1.41930992 |
124 | Tubulointerstitial abnormality (HP:0001969) | 1.39706355 |
125 | Purpura (HP:0000979) | 1.38631257 |
126 | Abnormality of the calf musculature (HP:0001430) | 1.34371708 |
127 | Rimmed vacuoles (HP:0003805) | 1.32509382 |
128 | Difficulty running (HP:0009046) | 1.32203767 |
129 | Neonatal onset (HP:0003623) | 1.30428722 |
130 | Premature birth (HP:0001622) | 1.28294521 |
131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.26449259 |
132 | Neck muscle weakness (HP:0000467) | 1.22474425 |
133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.20485813 |
134 | Paresthesia (HP:0003401) | 1.19633731 |
135 | Osteopenia (HP:0000938) | 1.19006271 |
136 | Epistaxis (HP:0000421) | 1.15778603 |
137 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.13887686 |
138 | Abnormality of the renal medulla (HP:0100957) | 1.12919276 |
139 | Polyhydramnios (HP:0001561) | 1.11065284 |
140 | Metaphyseal dysplasia (HP:0100255) | 1.10937053 |
141 | Hip contracture (HP:0003273) | 1.10830898 |
142 | Thyroid-stimulating hormone excess (HP:0002925) | 1.10594610 |
143 | Distal lower limb muscle weakness (HP:0009053) | 1.06933801 |
144 | Frequent falls (HP:0002359) | 1.06558672 |
145 | Subaortic stenosis (HP:0001682) | 1.06125690 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 8.47777795 |
2 | OXSR1 | 7.83780214 |
3 | WNK3 | 7.81234107 |
4 | STK39 | 5.46185947 |
5 | BCKDK | 2.89348018 |
6 | MST4 | 2.00987765 |
7 | STK38L | 1.85421947 |
8 | ERN1 | 1.65253097 |
9 | AKT3 | 1.64222056 |
10 | WNK1 | 1.63218019 |
11 | FRK | 1.59678875 |
12 | PDK2 | 1.55388462 |
13 | LATS1 | 1.53372799 |
14 | SGK223 | 1.52494468 |
15 | SGK494 | 1.52494468 |
16 | PDK3 | 1.40585136 |
17 | PDK4 | 1.40585136 |
18 | SGK2 | 1.14394467 |
19 | SGK3 | 1.02400656 |
20 | NEK1 | 0.98968632 |
21 | TAOK3 | 0.92058054 |
22 | INSRR | 0.89299552 |
23 | STK38 | 0.86887375 |
24 | TIE1 | 0.86192518 |
25 | LRRK2 | 0.82969774 |
26 | MST1R | 0.77729494 |
27 | MYLK | 0.76155137 |
28 | BMX | 0.74169954 |
29 | TGFBR2 | 0.70577891 |
30 | EIF2AK1 | 0.64673075 |
31 | PINK1 | 0.60651344 |
32 | SIK1 | 0.57354638 |
33 | PTK6 | 0.57198264 |
34 | PRKAA1 | 0.54719555 |
35 | MAP3K7 | 0.54394732 |
36 | SCYL2 | 0.54028000 |
37 | MAP3K2 | 0.49379937 |
38 | MAP3K3 | 0.48677614 |
39 | PTK2B | 0.48104362 |
40 | DMPK | 0.48059047 |
41 | EPHB1 | 0.46755841 |
42 | GSK3A | 0.44991520 |
43 | SGK1 | 0.43822061 |
44 | STK24 | 0.43419062 |
45 | EEF2K | 0.41983326 |
46 | PDPK1 | 0.41383189 |
47 | TEC | 0.40559334 |
48 | PIK3CG | 0.40264306 |
49 | MAPKAPK3 | 0.37810462 |
50 | RIPK4 | 0.37504874 |
51 | FER | 0.36184764 |
52 | PRKCI | 0.35979927 |
53 | TNIK | 0.35856943 |
54 | STK10 | 0.35275863 |
55 | TRIB3 | 0.35089081 |
56 | PRKD2 | 0.35066191 |
57 | BRSK2 | 0.34145846 |
58 | FGFR4 | 0.32080804 |
59 | PRKAA2 | 0.31357347 |
60 | MAP2K4 | 0.31208574 |
61 | NLK | 0.30681446 |
62 | PTK2 | 0.28270126 |
63 | PDGFRA | 0.26703305 |
64 | PDK1 | 0.26462775 |
65 | ZAP70 | 0.25722565 |
66 | PNCK | 0.25674944 |
67 | PAK4 | 0.24722276 |
68 | BTK | 0.24669312 |
69 | NEK9 | 0.24339721 |
70 | TRIM28 | 0.23734984 |
71 | TTN | 0.23627278 |
72 | ERBB3 | 0.23617989 |
73 | NUAK1 | 0.23050519 |
74 | LMTK2 | 0.20959613 |
75 | MAP2K3 | 0.20489035 |
76 | JAK2 | 0.20212175 |
77 | MET | 0.19978538 |
78 | MUSK | 0.19918155 |
79 | ABL2 | 0.18632309 |
80 | PLK2 | 0.18281353 |
81 | ACVR1B | 0.18049535 |
82 | NEK6 | 0.17350536 |
83 | MAP3K14 | 0.17276856 |
84 | PRKG1 | 0.17031810 |
85 | GRK5 | 0.16622733 |
86 | TRPM7 | 0.16097763 |
87 | PRKACA | 0.16025092 |
88 | STK3 | 0.16003143 |
89 | FGR | 0.15563057 |
90 | MAPK11 | 0.15184324 |
91 | NME1 | 0.14344898 |
92 | RET | 0.13572241 |
93 | NTRK1 | 0.13235980 |
94 | PAK3 | 0.13053691 |
95 | PRKCZ | 0.12625298 |
96 | IRAK3 | 0.12611275 |
97 | CSF1R | 0.12590938 |
98 | TNK2 | 0.11756474 |
99 | BMPR1B | 0.11434869 |
100 | TGFBR1 | 0.11225715 |
101 | CAMK2G | 0.11175115 |
102 | AKT2 | 0.10910939 |
103 | ILK | 0.10745008 |
104 | ROCK1 | 0.10637869 |
105 | DYRK1B | 0.10598051 |
106 | MAP2K1 | 0.10139026 |
107 | EPHA3 | 0.09588075 |
108 | JAK1 | 0.09526163 |
109 | MAP2K2 | 0.09260603 |
110 | ARAF | 0.09171081 |
111 | MAP3K5 | 0.08884389 |
112 | MAPK12 | 0.08662913 |
113 | CCNB1 | 0.07625885 |
114 | HCK | 0.07443711 |
115 | IRAK1 | 0.07172214 |
116 | PRKCH | 0.07109764 |
117 | MARK3 | 0.06714839 |
118 | MTOR | 0.06306152 |
119 | EPHA2 | 0.05951245 |
120 | PKN1 | 0.05878720 |
121 | STK11 | 0.05848232 |
122 | YES1 | 0.05840605 |
123 | RIPK1 | 0.05561303 |
124 | PKN2 | 0.05338259 |
125 | SYK | 0.05250692 |
126 | PRKCA | 0.05072090 |
127 | PRKCQ | 0.04950867 |
128 | MAP3K12 | 0.04914262 |
129 | PAK1 | 0.04362109 |
130 | JAK3 | 0.04295172 |
131 | PRKCD | 0.04118937 |
132 | OBSCN | 0.04020441 |
133 | PIK3CA | 0.04009812 |
134 | MOS | 0.03566582 |
135 | PRKD1 | 0.03513248 |
136 | PRKCB | 0.03427401 |
137 | EPHB2 | 0.03167991 |
138 | CSNK1A1 | 0.03130505 |
139 | PRKACG | 0.03102376 |
140 | KSR2 | 0.03084169 |
141 | CAMK2D | 0.03036523 |
142 | KSR1 | 0.02522414 |
143 | EIF2AK3 | 0.02421771 |
144 | ADRBK2 | 0.01407803 |
145 | PHKG1 | 0.01098918 |
146 | PHKG2 | 0.01098918 |
147 | TAOK1 | 0.00943755 |
148 | RAF1 | 0.00841425 |
149 | ADRBK1 | 0.00809913 |
150 | MAP3K4 | 0.00623248 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.52511592 |
2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.50300249 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.47330157 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.15365526 |
5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.08821345 |
6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.00070149 |
7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.92011000 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91093838 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63049321 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.60395157 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.44961538 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.37871428 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37751611 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.36801965 |
15 | Platelet activation_Homo sapiens_hsa04611 | 2.28466610 |
16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.23692394 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.20855022 |
18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.17111129 |
19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.08838961 |
20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04095663 |
21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.91396778 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82816344 |
23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.77215678 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74826160 |
25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.70620198 |
26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70277944 |
27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67640555 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64682367 |
29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61581375 |
30 | Bile secretion_Homo sapiens_hsa04976 | 1.59344220 |
31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56166600 |
32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55936463 |
33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.52239199 |
34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51034275 |
35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48956178 |
36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48948671 |
37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44436279 |
38 | Lysine degradation_Homo sapiens_hsa00310 | 1.44317011 |
39 | Mineral absorption_Homo sapiens_hsa04978 | 1.33046879 |
40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.24878811 |
41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24664559 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19510295 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14819910 |
44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14747719 |
45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10026878 |
46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08869603 |
47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06757025 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02809646 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02480565 |
50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02071054 |
51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00409656 |
52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96195672 |
53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96063791 |
54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95558150 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93049877 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91153897 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87923906 |
58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86955449 |
59 | Lysosome_Homo sapiens_hsa04142 | 0.85527182 |
60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83160931 |
61 | Adherens junction_Homo sapiens_hsa04520 | 0.83145951 |
62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82495497 |
63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79534595 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76512383 |
65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74641900 |
66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71023498 |
67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70201333 |
68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68615282 |
69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67073842 |
70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66687496 |
71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66172878 |
72 | * Focal adhesion_Homo sapiens_hsa04510 | 0.65560004 |
73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65020043 |
74 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63025564 |
75 | ABC transporters_Homo sapiens_hsa02010 | 0.60937318 |
76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60127586 |
77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59153850 |
78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58819674 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57714377 |
80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55289472 |
81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55256029 |
82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53647941 |
83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52393643 |
84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49176696 |
85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48427579 |
86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47376875 |
87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47289829 |
88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45960737 |
89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45102184 |
90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43705803 |
91 | * Gap junction_Homo sapiens_hsa04540 | 0.43218920 |
92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42966451 |
93 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42853189 |
94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42778665 |
95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39814307 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37763687 |
97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35961091 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.35534546 |
99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34385202 |
100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30134942 |
101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29643706 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29622633 |
103 | Renin secretion_Homo sapiens_hsa04924 | 0.29374417 |
104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29181961 |
105 | Protein export_Homo sapiens_hsa03060 | 0.28671531 |
106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28385566 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27755696 |
108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27521119 |
109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27152680 |
110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26375892 |
111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25987237 |
112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25434427 |
113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23858757 |
114 | Tight junction_Homo sapiens_hsa04530 | 0.23289037 |
115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19778130 |
116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16576734 |
117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15534820 |
118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14656667 |
119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.14286032 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14024813 |
121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.11578072 |
122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11431104 |
123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.08548912 |
124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06526993 |
125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.06006072 |
126 | Amoebiasis_Homo sapiens_hsa05146 | 0.05930530 |
127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.05460347 |
128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05042587 |
129 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.03198361 |
130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.03152416 |
131 | Parkinsons disease_Homo sapiens_hsa05012 | 0.03043934 |